Amanda Jamieson is the Esther Elizabeth Brintzenhoff Associate Professor of Molecular Microbiology and Immunology at Brown University. She also is a director of the Pathobiology Graduate Program and the NIH- post-bac program. Dr Jamieson completed a PhD at UC Berkeley and a post-doctoral fellowship at Yale University School of Medicine and the Max F. Perutz Laboratories in Vienna, Austria before coming to Brown. Her lab studies how the lung orchestrates the local and systemic innate immune responses. She takes a unique collaborative and multi-disciplinary approach to understanding the interplay between the immune system, the neural system, and the vasculature in infection, injury, and cancer.
"The lung, the niche, and the microbe: Exploring the lung microbiome in cancer and immunity." 2023. |
FitzGerald ES, Jamieson AM. "Comment on 'SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung'." eLife, vol. 11, 2022. |
Jamieson AM. "Probing the early upper respiratory responses to SARS-CoV-2." Physiological reports, vol. 9, no. 9, 2021, pp. e14836. |
Crane, Meredith J., Henry, William L., Tran, Holly L., Albina, Jorge E., Jamieson, Amanda M. "Assessment of Acute Wound Healing using the Dorsal Subcutaneous Polyvinyl Alcohol Sponge Implantation and Excisional Tail Skin Wound Models." Journal of Visualized Experiments, no. 157, 2020. |
FitzGerald ES, Luz NF, Jamieson AM. "Competitive Cell Death Interactions in Pulmonary Infection: Host Modulation Versus Pathogen Manipulation." Frontiers in immunology, vol. 11, 2020, pp. 814. |
Serpa GL, Renton ND, Lee N, Crane MJ, Jamieson AM. "Electronic Nicotine Delivery System Aerosol-induced Cell Death and Dysfunction in Macrophages and Lung Epithelial Cells." American Journal of Respiratory Cell and Molecular Biology, vol. 63, no. 3, 2020, pp. 306-316. |
Crane, Meredith J., Xu, Yun, Monaghan, Sean F., Hall, Benjamin M., Albina, Jorge E., Henry, William L., Tran, Holly L., Chhabria, Karisma R. P., Jordon, Alexander R. D., Carlsen, Lindsey, Jamieson, Amanda M. "Pulmonary infection interrupts acute cutaneous wound healing through disruption of chemokine signals." [], 2020. |
FitzGerald, Ethan S., Jamieson, Amanda M. "Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies." [], 2020. |
Lee K, Cohen JT, Wilson ZS, Zhao R, Lomas-Neira J, Chung CS, Chen Y, Jamieson AM, Ayala A, Lefort CT. "Hemorrhage Attenuates Neutrophil Recruitment in Response to Secondary Respiratory Infection by Pseudomonas Aeruginosa." SHOCK, vol. 52, no. 5, 2019, pp. 506-512. |
Crane MJ, Xu Y, Henry WL Jr, Gillis SP, Albina JE, Jamieson AM. "Pulmonary influenza A virus infection leads to suppression of the innate immune response to dermal injury." PLoS pathogens, vol. 14, no. 8, 2018, pp. e1007212. |
Meredith J. CraneKayla M. Lee, Ethan S. FitzGerald and Amanda M. Jamieson. "Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System." Frontiers in immunology, 2018. |
Crane, Meredith J., Lee, Kayla M., FitzGerald, Ethan S., Jamieson, Amanda M. "Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System." Frontiers in Immunology, vol. 9, 2018. |
Crane MJ, Lee KM, FitzGerald ES, Jamieson AM. "Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System." Frontiers in immunology, vol. 9, 2018, pp. 1421. |
Gamradt P, Xu Y, Gratz N, Duncan K, Kobzik L, Högler S, Kovarik P, Decker T, Jamieson AM. "Correction: The Influence of Programmed Cell Death in Myeloid Cells on Host Resilience to Infection with Legionella pneumophila or Streptococcus pyogenes." PLoS pathogens, vol. 13, no. 8, 2017, pp. e1006591. |
Clark SE, Filak HC, Guthrie BS, Schmidt RL, Jamieson A, Merkel P, Knight V, Cole CM, Raulet DH, Lenz LL. "Bacterial Manipulation of NK Cell Regulatory Activity Increases Susceptibility to Listeria monocytogenes Infection." PLoS pathogens, vol. 12, no. 6, 2016, pp. e1005708. |
Amanda M. Jamieson.
"Host Resilience to Emerging Coronaviruses." Future Virology, 2016.
|
Jamieson AM. "Host resilience to emerging coronaviruses." Future Virology, vol. 11, no. 7, 2016, pp. 529-534. |
Gamradt P, Xu Y, Gratz N, Duncan K, Kobzik L, Högler S, Kovarik P, Decker T, Jamieson AM. "The Influence of Programmed Cell Death in Myeloid Cells on Host Resilience to Infection with Legionella pneumophila or Streptococcus pyogenes." PLoS pathogens, vol. 12, no. 12, 2016, pp. e1006032. |
Castiglia V, Piersigilli A, Ebner F, Janos M, Goldmann O, Damböck U, Kröger A, Weiss S, Knapp S, Jamieson AM, Kirschning C, Kalinke U, Strobl B, Müller M, Stoiber D, Lienenklaus S, Kovarik P. "Type I Interferon Signaling Prevents IL-1β-Driven Lethal Systemic Hyperinflammation during Invasive Bacterial Infection of Soft Tissue." Cell Host & Microbe, vol. 19, no. 3, 2016, pp. 375-87. |
Jamieson AM. "Influence of the microbiome on response to vaccination." Human Vaccines & Immunotherapeutics, 2015, pp. 0. |
Wienerroither S, Rauch I, Rosebrock F, Jamieson AM, Bradner J, Muhar M, Zuber J, Müller M, Decker T. "Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins." Molecular and Cellular Biology, vol. 34, no. 3, 2014, pp. 415-27. |
Paolino M, Choidas A, Wallner S, Pranjic B, Uribesalgo I, Loeser S, Jamieson AM, Langdon WY, Ikeda F, Fededa JP, Cronin SJ, Nitsch R, Schultz-Fademrecht C, Eickhoff J, Menninger S, Unger A, Torka R, Gruber T, Hinterleitner R, Baier G, Wolf D, Ullrich A, Klebl BM, Penninger JM. "The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells." Nature, vol. 507, no. 7493, 2014, pp. 508-12. |
Putz EM, Gotthardt D, Hoermann G, Csiszar A, Wirth S, Berger A, Straka E, Rigler D, Wallner B, Jamieson AM, Pickl WF, Zebedin-Brandl EM, Müller M, Decker T, Sexl V. "CDK8-mediated STAT1-S727 phosphorylation restrains NK cell cytotoxicity and tumor surveillance." Cell Reports, vol. 4, no. 3, 2013, pp. 437-44. |
Jamieson AM, Pasman L, Yu S, Gamradt P, Homer RJ, Decker T, Medzhitov R. "Role of tissue protection in lethal respiratory viral-bacterial coinfection." Science, vol. 340, no. 6137, 2013, pp. 1230-4. |
Aubry C, Corr SC, Wienerroither S, Goulard C, Jones R, Jamieson AM, Decker T, O'Neill LA, Dussurget O, Cossart P. "Both TLR2 and TRIF contribute to interferon-β production during Listeria infection." PLoS ONE, vol. 7, no. 3, 2012, pp. e33299. |
Kernbauer E, Maier V, Stoiber D, Strobl B, Schneckenleithner C, Sexl V, Reichart U, Reizis B, Kalinke U, Jamieson A, Müller M, Decker T. "Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infection." PLoS pathogens, vol. 8, no. 6, 2012, pp. e1002763. |
Farlik M, Rapp B, Marie I, Levy DE, Jamieson AM, Decker T. "Contribution of a TANK-binding kinase 1-interferon (IFN) regulatory factor 7 pathway to IFN-γ-induced gene expression." Molecular and Cellular Biology, vol. 32, no. 6, 2012, pp. 1032-43. |
Jamieson AM, Farlik M, Decker T.
"How Stats interact with the molecular machinery of transcriptional activation." Jak-Stat Signaling: From Basics to Disease, Springer, 2012, pp. p.65-89.
|
Kernbauer, Elisabeth, Jamieson, Amanda M., Schneckenleithner, Christine, Sexl, Veronika, Reichart, Ursula, Strobl, Birgit, Müller, Mathias, Decker, Thomas. "CS04-5. Conditional ablation of Stat1 reveals the antagonistic role of interferons in the clearance of the intracellular bacterial pathogen Listeria monocytogenes." Cytokine, vol. 56, no. 1, 2011, pp. 10-11. |
Jamieson AM, Yu S, Annicelli CH, Medzhitov R. "Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection." Cell Host & Microbe, vol. 7, no. 2, 2010, pp. 103-14. |
Nogueira CV, Lindsten T, Jamieson AM, Case CL, Shin S, Thompson CB, Roy CR. "Rapid pathogen-induced apoptosis: a mechanism used by dendritic cells to limit intracellular replication of Legionella pneumophila." PLoS pathogens, vol. 5, no. 6, 2009, pp. e1000478. |
Singh R, Jamieson A, Cresswell P. "GILT is a critical host factor for Listeria monocytogenes infection." J. Geophys. Res., vol. 455, no. 7217, 2008, pp. 1244-7. |
Lackman RL, Jamieson AM, Griffith JM, Geuze H, Cresswell P. "Innate immune recognition triggers secretion of lysosomal enzymes by macrophages." Traffic (Copenhagen, Denmark), vol. 8, no. 9, 2007, pp. 1179-89. |
Arina A, Murillo O, Hervás-Stubbs S, Azpilikueta A, Dubrot J, Tirapu I, Huarte E, Alfaro C, Pérez-Gracia JL, González-Aseguinolaza G, Sarobe P, Lasarte JJ, Jamieson A, Prieto J, Raulet DH, Melero I. "The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFN gamma." International Journal of Cancer, vol. 121, no. 6, 2007, pp. 1282-95. |
Pinto AK, Jamieson AM, Raulet DH, Hill AB. "The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40." Journal of Virology, vol. 81, no. 22, 2007, pp. 12564-71. |
Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. "A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules." Blood, vol. 105, no. 11, 2005, pp. 4416-23. |
Street SE, Hayakawa Y, Zhan Y, Lew AM, MacGregor D, Jamieson AM, Diefenbach A, Yagita H, Godfrey DI, Smyth MJ. "Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells." Journal of Experimental Medicine, vol. 199, no. 6, 2004, pp. 879-84. |
Carlyle JR, Jamieson AM, Gasser S, Clingan CS, Arase H, Raulet DH. "Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors." Proceedings of the National Academy of Sciences, vol. 101, no. 10, 2004, pp. 3527-32. |
Jamieson, A.M., Diefenbach, A., McMahon, C.W., Xiong, N., Carlyle, J.R., Raulet, D.H. "The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing." Immunity, vol. 20, no. 6, 2004, pp. 799. |
Jamieson AM, Isnard P, Dorfman JR, Coles MC, Raulet DH. "Turnover and proliferation of NK cells in steady state and lymphopenic conditions." The Journal of Immunology, vol. 172, no. 2, 2004, pp. 864-70. |
Junqueira-Kipnis AP, Kipnis A, Jamieson A, Juarrero MG, Diefenbach A, Raulet DH, Turner J, Orme IM. "NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection." The Journal of Immunology, vol. 171, no. 11, 2003, pp. 6039-45. |
Vance RE, Jamieson AM, Cado D, Raulet DH. "Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation." Proceedings of the National Academy of Sciences, vol. 99, no. 2, 2002, pp. 868-73. |
Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK, Vivier E, Raulet DH. "Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D." Nature Immunology, vol. 3, no. 12, 2002, pp. 1142-9. |
Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. "The role of the NKG2D immunoreceptor in immune cell activation and natural killing." Immunity, vol. 17, no. 1, 2002, pp. 19-29. |
McMahon CW, Zajac AJ, Jamieson AM, Corral L, Hammer GE, Ahmed R, Raulet DH. "Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells." The Journal of Immunology, vol. 169, no. 3, 2002, pp. 1444-52. |
Tanamachi DM, Hanke T, Takizawa H, Jamieson AM, Raulet DR. "Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules." Journal of Experimental Medicine, vol. 193, no. 3, 2001, pp. 307-15. |
Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. "Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity." J. Geophys. Res., vol. 413, no. 6852, 2001, pp. 165-71. |
Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. "Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages." Nature Immunology, vol. 1, no. 2, 2000, pp. 119-26. |
Corral L, Takizawa H, Hanke T, Jamieson AM, Raulet DH. "A new monoclonal antibody reactive with several Ly49 NK cell receptors mediates redirected lysis of target cells." Hybridoma, vol. 18, no. 4, 1999, pp. 359-66. |
Vance RE, Jamieson AM, Raulet DH. "Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells." Journal of Experimental Medicine, vol. 190, no. 12, 1999, pp. 1801-12. |
Radler J, Koltover I, Jamieson AM, Salditt T, Safinya CR. "Structure and Interfacial Aspects of Self-Assembled Cationic Lipid-DNA Gene Carrier Complexes." Langmuir : the ACS journal of surfaces and colloids., vol. 14, 1998, pp. 4272. |
The overarching focus of my research program is understanding how the immune system can respond to multiple inflammatory insults at the same time. I am specifically interested in how the lung orchestrates the local, organismal, and systemic responses. We are specifically interested in understanding the interplay between the immune system, the neural system, and the vasculature. I have also been at the forefront of understanding host tolerance, which is the concept that in order to survive an infection the host must not only clear the pathogen but withstand changes to homeostasis triggered by both the pathogen and the host response. My laboratory has two main interrelated areas of focus: 1) Understanding host disease tolerance and the role of the respiratory microbiome in the innate immune response to complex respiratory infections and cancer, and 2) Understanding how the immune system responds to two competing inflammatory insults or “immune triage”. In order to study these topics, I am taking a unique multidisciplinary approach which involves collaborations with pulmonologists, surgeons, bioengineers, and neuroscientists. My lab has developed innovative new models to study the molecular details of viral/bacterial pulmonary coinfections, tissue resilience during pulmonary infection and injury, the lung microbiome in cancer, and innate immune prioritization of lung infections over cutaneous injury. My interdisciplinary approach will shape the field’s understanding of the control and regulation of the innate immune response at a systemic level.
Active Research Support
2R25GM125500-06 Aizenman PI, Campbell, MPI Jamieson, MPI 2023-28
Funding Source: NIH/NIGMS
Brown University Postbaccalaureate Research Education Progam
This grant supports the education of future PhD level scientists to promote diversity in the scientific workforce.
R01HL165259-01A1 Jamieson, PI 2023-27
Funding Source: NIH/NHLBI/NIGMS
Central role of Caspase-8 in control of host tolerance and resistance mechanisms in pulmonary macrophage populations during severe respiratory infections
This grant uses genetic mouse models and in vitro experiments to determine how Caspase-8 controls the balance between host resistance and tolerance to influenza A virus/bacterial coinfections.
Rhode Island Foundation Grant Resubmission Grant Jamieson, PI 2023-24
Funding Source: RIF
Targeting Caspase-8 as a potential therapeutic for complex lung infections
To develop nanocarrier technology that directly targets macrophages to demonstrate the role that this targeting has for a potential therapeutic benefits.
Seed Award Jamieson, PI (co-PI Abbasi) 2023-24
Funding Source: Brown University
Causes of dangerous short-term and long-term coagulation issues with SARS-CoV-2 and other potential pandemic respiratory virus infections
This project is a collaboration with a PI at RIH. We will obtain plasma from patients with SARS-CoV-2 and other respiratory infections to look at tissue factor on circulating extracellular vesicles.
NHLBI R01HL126887 Jamieson (PI) 2018-23
Funding source: NIH/NHLBI
Influence of the lung microbiome on macrophage responses to lung damage
Completed Research Support
NHLBI 3R01HL126887-02S1 Jamieson (PI) 2020-23
Funding source: NIH/NHLBI
Research Supplement to Promote Diversity in Health-Related Research
Center for Antimicrobial Resistance and Therapeutic Discovery Pilot Project Jamieson, PI 2022-23
Funding source: CARTD, Miriam Hospital
Acquisition of anti-microbial tolerance caused by lung infection-induced hypoxia
Carney Institute Innovation Awards Jamieson, PI 2020-22
Funding source: Carney Institute for Brain Science, Brown University
Neural control of Innate Immune Prioritization
Innovation Voucher Jamieson (PI) 2020-21
Funding Source: Rhode Island Department of Commerce
Testing the Virucidal Activity of Graphene Composite Ink on Filters to Make Building Ventilation Systems Safer.
FAST Grants Award #2170 Jamieson (PI) 2020-21
Funding Source: Emergent Ventures Mercatus Center, George Mason University
Treating COVID-19: From host tolerance to anti-viral strategies
COVID-19 Seed Award Jamieson (PI) 2020-21
Funding Source: Brown University
Determining immunity at a population level in Rhode Island to the novel coronavirus SARS-CoV2
COVID-19 Seed Award Jamieson (PI) 2020-21
Funding Source: Brown University
GC-coronavirus-killing ink: testing
NIGMS P20GM109035 Jamieson Jr. Investigator, PI Rand 2016-21
Funding Source NIH/NIGMS Graduated 2019
COBRE Center for Computational Biology of Human Disease Project 3:Tolerance of Viral/bacterial co-infections
Brown University Seed Award Jamieson (Co-PI) 2019-20
With Co-PI Dr. Anita Shukla, Brown Engineering
Enhancing Wound Healing Using Hydrogels for Localized Chemokine and Cytokine Delivery
DARPA Director’s Award Jamieson (PI) 2017-19 Funding source: Defense Advanced Research Project Agency (DARPA)
Influence of pulmonary infections on the wound healing response.
RI-INBRE Early Career Award Jamieson (PI) 2015-17
Funding source: NIGMS
The impact of e-cigarette vapor on the pulmonary stress response
Initial AIDS Research Project Jamieson (PI) 2015-16 Funding source: Defense Advanced Funding Source Center for Aids Research (CFAR)
Tolerance of HIV-Related Immune Reconstitution Inflammatory Syndrome
Medical Research Funds Jamieson (PI) 2015-16 Funding source: Rhode Island Foundation
Influence of the airway microbiome on response to pulmonary infection
DARPA Young Faculty Award Jamieson (PI) 2015-17 Funding source: Defense Advanced Research Project Agency (DARPA)
Influence of the airway microbiome on the tolerance response to pulmonary infections.
Brazil Initiative Collaboration Award Jamieson, de Graffenried, Zamboni (Co-PIs) 2014-16
Funding Source: Watson Institute
The Effect of Cellular Morphology of Endemic Brazilian Leishmania species on Host Immune Response and Disease Progression
Dean’s Emerging Areas of New Science Awards (DEANS) Jamieson and Albina (co-PIs) 2014-15 Funding Source: Brown University
Post-surgical pneumonia and development of wound repair macrophages
Pilot Grant from 5P20GM103652 Jamieson (PI) 2014-15
Funding source: NIH/NIGMS Ocean State Research Institute (OSRI) CardioPulmonary Vascular Biology (CPVB) COBRE Impact of influenza virus/L. pneumophila coinfection on lung endothelial cells
.
Salomon Research Award Jamieson (PI) 2014-15
Funding Source: Brown University
Understanding the interaction of the airway microbiome with pulmonary diseases
FWF Grant P25235-B13 Jamieson (PI) 2012-14
Funding Source: Austrian Science Fund (FWF)
Tolerance to viral/bacterial coinfections
FWF Grant SFB-F28 Jamieson and Decker (co-PIs) 2009-13
Funding Source: Austrian Science Fund (FWF)
JAK-STAT signaling in health and disease
Year | Degree | Institution |
---|---|---|
2004 | PhD | University of California, Berkeley |
1997 | BA | Carleton College |
2022
Class of ’97 Distinguished Achievement Award, Carleton College
2021
Dean’s Award for Excellence in Undergraduate Teaching, Advising, and Mentoring in the Biological Sciences
Elected as co-chair for Midwinter Conference of Immunologists
2020
Elected to the Office of Women in Science and Medicine Advisory Board
Selected as Faculty Speaker for Brown University Biology Department Graduation
Postponed until 2021 due to COVID-19
2019
Elected to the Midwinter Conference of Immunologists Council
Selected as Sheridan Center Junior Faculty Teaching Fellow
Elected to the University Resources Committee (Vice Chair 2 years)
Dean’s Research Award
2018
Awarded the Society for Leukocyte Biology Women and Diversity Paper of the Year Award
Dean’s Research Award
2017
Dean’s Research Award
2014
Salomon Research Award
2012
Innate Immunity Keystone Scholarship
2004
Berger foundation fellow of the Damon Runyon Cancer Research Foundation
2002
Society for Natural Immunity travel award
1998
Graduate Division travel award
Cancer Research Laboratory (CRL) Training Grant
National Science Foundation Graduate Research Fellowship Honorable Mention
1997
Phi Beta Kappa Honor Society
summa cum laude Carleton College
Name | Title |
---|---|
Albina, Jorge | Professor Emeritus of Surgery |
Ayala, Alfred | Professor of Surgery (Research) |
Belenky, Peter | Associate Professor of Molecular Microbiology and Immunology |
de Graffenried, Christopher | Associate Professor of Molecular Microbiology and Immunology |
Eberson, Craig | Professor of Orthopaedics |
Harrington, Elizabeth | Associate Dean for Graduate Studies, Professor of Medicine |
Lee, Chun Geun | Professor of Molecular Microbiology and Immunology (Research) |
Lefort, Craig | Associate Professor of Surgery (Research) |
McKinney, Robin | Associate Professor of Pediatrics, Clinician Educator |
Monaghan, Sean | Associate Professor of Surgery |
Moore, Christopher | Associate Director of the Carney Institute of Brain Science, Professor of Neuroscience, Professor of Brain Science |
Plavicki, Jessica | Associate Professor of Pathology and Laboratory Medicine |
Rounds, Sharon | Associate Dean for Translational Science, Professor of Medicine, Professor of Pathology and Laboratory Medicine |
Shukla, Anita | Elaine I. Savage Professor of Engineering, Professor of Engineering |
Vaishnava, Shipra | Esther Elizabeth Brintzenhoff Associate Professor of Molecular Microbiology and Immunology |
Wu, Zhijin | Director of the Doctoral Program in Biostatistics, Professor of Biostatistics |
Zhou, Yang | Assistant Professor of Molecular Microbiology and Immunology |
Solving for Science 2022-present
Society for Mucosal Immunology 2021-present
Society for Redox Medicine 2020-present
American Thoracic Society 2018-present
Society of Leukocyte Biology 2017-present
American Association for the Advancement of Science 2016-present
American Society for Microbiology 2014-present
American Society for Immunology 2000-present
Legoretta Cancer Center Member. Legorreta Cancer Center at Brown University, 2022- |
co-Director of NIH PREP Program. Brown University , 2022- |
Currently teaching Virology-BIOL 1560. This class explores molecular virology with an emphasis on human disease and the immune response. It will be offered again in the fall of 2018.
Past Teaching Experience:
Spring 2018
Fall 2017
Spring 2017
Fall 2016
Spring 2016
Fall 2015
Spring 2015 Course head of Virology, Brown University
Fall 2014 Guest Lecturer for Innate Immunity Course, Brown University MMI
Spring 2014 Guest Lecturer for: “Human Biology for Epidemiology” (PHP 2130)
Fall 2013 Guest Lecturer for Innate Immunity Course, Brown University MMI
2009-2013 Instructor/Lecturer, University of Vienna
Spring 2001 Graduate Student Instructor, University of California at Berkeley
Fall 1999 Graduate Student Instructor, University of California at Berkeley
Fall 1998 Graduate Student Instructor, University of California at Berkeley
Fall 1998 Participated in Graduate Student Instructor (GSI) training course
1995-1996 Teaching Assistant, Carleton College
BIOL 1560 - Virology |
BIOL 2560 - Advanced Virology |
BIOL 2565 - Advanced Virology for Biotechnology |